<p>Congenitally corrected transposition of the great arteries (ccTGA) with biventricular physiology is presumed to carry a favorable outcome. We aimed to explore the differences in associated diagnoses (including conduction disease), management and outcomes among prenatally vs. postnatally diagnosed ccTGA cases. Secondary objective was to examine outcomes in isolated ccTGA. An international, multicenter, retrospective cohort study was conducted in 29 tertiary hospitals (6 countries) from 1990 to 2018. Patients with a single ventricle, heterotaxy syndrome, or valvar atresia were excluded. Of 331 ccTGA patients with a median follow-up of 8.6 years [IQR: 3.5–14.1], 128 (38.7%) were diagnosed prenatally at a median gestational age of 22 weeks. As compared to the postnatal group, prenatally diagnosed patients experienced earlier cardiac conduction disorders (median age at diagnosis of conduction disorders: 0.3 versus 2.7 years, <i>p</i> = 0.010), earlier pacemaker implantation (median age at pacing: 6.5 years [2.5–11.6] versus 0.9 year [0.1-3.0], <i>p</i> &lt; 0.001) and earlier surgical intervention (intervention-free survival rate at 3 years: 50.3% versus 34.7%, <i>p</i> &lt; 0.001). The 3-year survival rate was significantly lower in patients diagnosed prenatally (91.1% versus 98.4%, <i>p</i> = 0.002) and the median age at death was significantly younger among patients diagnosed prenatally (0.2 versus 7.0 years, <i>p</i> &lt; 0.001). In both groups, isolated ccTGA (<i>n</i> = 63, 19%) was associated with superior outcomes with no intervention in 46.8% and only one death. Prenatally diagnosed patients with ccTGA had earlier conduction disorders and interventions than postnatally diagnosed patients and died at a younger age. Outcomes were best in patients with isolated ccTGA.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Prenatally vs. Postnatally Diagnosed Congenitally Corrected Transposition of the Great Arteries is Associated with Higher Rates of Conduction Disease, Intervention and Earlier Mortality

  • Lynne E. Nield,
  • Mélanie Grasswill,
  • Bénédicte Romefort,
  • Solène Prigent,
  • Emre Belli,
  • Sonya V. Babu-Narayan,
  • Robert W. Elder,
  • Magalie Ladouceur,
  • Paul Khairy,
  • Ewa Kowalik,
  • David M. Kalfa,
  • Miriam Conway,
  • Oscar Werner,
  • Jean-Marc Sellal,
  • Astrid Monier,
  • Edward Buratto,
  • Paul Padovani,
  • David J. Barron,
  • Emile A. Bacha,
  • Michael A. Gatzoulis,
  • Christopher J. McLeod,
  • Matilde Karakachoff,
  • Alban-Elouen Baruteau,
  • Lynne E. Nield,
  • Mélanie Grasswill,
  • Bénédicte Romefort,
  • Solène Prigent,
  • Emre Belli,
  • Sonya V. Babu-Narayan,
  • Robert W. Elder,
  • Magalie Ladouceur,
  • Paul Khairy,
  • Ewa Kowalik,
  • David M. Kalfa,
  • Miriam Conway,
  • Oscar Werner,
  • Jean-Marc Sellal,
  • Edward Buratto,
  • David J. Barron,
  • Emile A. Bacha,
  • Michael A. Gatzoulis,
  • Christopher J. McLeod,
  • Matilde Karakachoff,
  • Alban-Elouen Baruteau,
  • Sylvia Abadir,
  • Angèle Boet,
  • Anne Charbonneau,
  • Nicolas Combes,
  • Guillaume Duthoit,
  • Christopher C. Erickson,
  • Emmanuelle Fournier,
  • Céline Grunenwald,
  • Nadir Benbrik,
  • Juha-Matti Happonen,
  • Bérengère Hiel,
  • Anita Hiippala,
  • Ali Houeijeh,
  • Clément Karsenty,
  • Matthias Lachaud,
  • Mathieu Le Bloa,
  • Laurianne Le Gloan,
  • Leonardo Liberman,
  • Caroline Martin-Bonnet,
  • Philippe Maury,
  • Shafi Mussa,
  • Caroline Ovaert,
  • Robert H. Pass,
  • Shubhayan Sanatani,
  • Joel Temple,
  • Jean-Benoit Thambo,
  • Guy Vaksmann,
  • Alain Fraisse,
  • George F. Van Hare

摘要

Congenitally corrected transposition of the great arteries (ccTGA) with biventricular physiology is presumed to carry a favorable outcome. We aimed to explore the differences in associated diagnoses (including conduction disease), management and outcomes among prenatally vs. postnatally diagnosed ccTGA cases. Secondary objective was to examine outcomes in isolated ccTGA. An international, multicenter, retrospective cohort study was conducted in 29 tertiary hospitals (6 countries) from 1990 to 2018. Patients with a single ventricle, heterotaxy syndrome, or valvar atresia were excluded. Of 331 ccTGA patients with a median follow-up of 8.6 years [IQR: 3.5–14.1], 128 (38.7%) were diagnosed prenatally at a median gestational age of 22 weeks. As compared to the postnatal group, prenatally diagnosed patients experienced earlier cardiac conduction disorders (median age at diagnosis of conduction disorders: 0.3 versus 2.7 years, p = 0.010), earlier pacemaker implantation (median age at pacing: 6.5 years [2.5–11.6] versus 0.9 year [0.1-3.0], p < 0.001) and earlier surgical intervention (intervention-free survival rate at 3 years: 50.3% versus 34.7%, p < 0.001). The 3-year survival rate was significantly lower in patients diagnosed prenatally (91.1% versus 98.4%, p = 0.002) and the median age at death was significantly younger among patients diagnosed prenatally (0.2 versus 7.0 years, p < 0.001). In both groups, isolated ccTGA (n = 63, 19%) was associated with superior outcomes with no intervention in 46.8% and only one death. Prenatally diagnosed patients with ccTGA had earlier conduction disorders and interventions than postnatally diagnosed patients and died at a younger age. Outcomes were best in patients with isolated ccTGA.